IDiyas

For the Inventor, By the Inventor

Paris, France

Stephane Bejanin

USPTO Granted Patents = 10

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 91(Granted Patents)


Company Filing History:

goldMedal8 out of 59 
 
Serono Genetics Institute S.a.
 patents
silverMedal1 out of 34 
 
Genset S.a.
 patents
bronzeMedal1 out of 2 
 
Serono Genetics Institute, Inc.
 patents

Years Active: 2004-2007

Loading Chart...
10 patents (USPTO):Explore Patents
1. 7291495 - β-Secretase variant (2007-11-06),
2. 7285631 - Human cDNAs and proteins and uses thereof (2007-10-23),
3. 7223727 - GSSP4 polynucleotides and polypeptides and uses thereof (2007-05-29),
4. 7122629 - Human cDNAs and proteins and uses thereof (2006-10-17),
5. 7094876 - Human cDNAs and proteins and uses thereof (2006-08-22),
6. 7074901 - Isolated human vCOL16A1 polypeptide and fragments thereof (2006-07-11),
7. 7074571 - Serine carboxypeptidase hx (SCPhx) and compositions thereof (2006-07-11),
8. 7005500 - Human cDNAs and proteins and uses thereof (2006-02-28),
9. 6989262 - Plasmin variants and uses thereof (2006-01-24),
10. 6794363 - Isolated amyloid inhibitor protein (APIP) and compositions thereof (2004-09-21),

Title: The Innovative Mind of Stephane Bejanin

Introduction

Stephane Bejanin, an accomplished inventor based in Paris, France, has made significant strides in the field of biotechnology. With a total of ten patents to his name, Bejanin has focused on pioneering inventions that address critical health issues, particularly in relation to amyloid beta precursor proteins and genetic expression.

Latest Patents

Among his latest innovations, Bejanin has developed a variant of beta-secretase, which presents a novel approach to creating polynucleotides and polypeptides that encode an isolated amyloid inhibitor protein (APIP). This invention aims to inhibit the sequential cleavage of amyloid beta precursor protein by beta and gamma secretases. Moreover, his patents also include advancements concerning GENSET polynucleotides and polypeptides, useful for forensic analyses, chromosome markers, and assays for diagnosing GENSET-related disorders.

Career Highlights

Stephane Bejanin has been associated with leading organizations such as the Serono Genetics Institute S.A. and Genset S.A., where he has contributed to groundbreaking research and development initiatives. His work across these esteemed institutions has allowed him to leverage advanced genetic technologies, propelling him into the forefront of biotechnology innovation.

Collaborations

Throughout his career, Bejanin has collaborated with talented professionals, including Hiroaki Tanaka and Barbara A. Chicca. These partnerships have undoubtedly expanded the scope of his research, contributing to the successful realization of his inventions.

Conclusion

In conclusion, Stephane Bejanin stands out as a remarkable inventor whose contributions to the fields of biotechnology and genetics have significant implications for the future of medical diagnostics and therapeutics. His continuous drive for innovation showcases the vital role of inventors in advancing science and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…